Enzyme is looking for a Senior Software Engineer, experienced in working with the full web stack, and someone who has owned/shipped production software for years. As a Senior Engineer, you'll be working an all areas of the app, from front end to UI, to backend automation, data management and NLP.
Every engineer at Enzyme not only has a voice in product decision, but also gets to see how their work influences all of our customers -- companies working on the most innovative new medical technology on the planet. You'll be joining an engineering team that strikes a balance between being lean and nimble, while also striving to deliver well-tested software the first go-around.
Successful candidates will have at least 5 years experience shipping production software at scale. Preference will be given to developers with experience in our stack (Rails + Ember), and experience working within life science or another regulated industry.
Imagine a world in which every new piece of medical technology -- every new chemo drug, pacemaker, Alzheimer’s therapy -- gets in the hands of patients 30% faster. That’s the world we’re building. And we’re looking for people who are motivated by the idea of being a force multiplier across an industry, and thus having a small hand in every new exciting technology being developed over the next 10 years.
Salary and equity grant will be commensurate with experience.
Think TurboTax, but for FDA.
We’re building a software platform to handle the compliance aspects of running a drug or medical device company. Compliance is an ongoing activity for companies in this space, and annual costs per company range anywhere from $100K to $100M. Being deemed not compliant can be devastating, preventing a company from selling any new product for months and sometimes years.
In lieu of hiring costly consultants or employees to address this problem, customers provide our platform access to their data, and the platform outputs documentation in the manner that FDA and other regulatory agencies are looking for.
By using our software platform, customers will cut their annual regulatory costs by 50% (on average) and reduce the risk that their products will not get approved for sale.